Kidist K Yimam, M.D.
Investigator
Dr. Kidist K. Yimam is a board‑certified transplant hepatologist and Medical Director of the Autoimmune Liver Diseases Program at California Pacific Medical Center (CPMC) in San Francisco. Since 2014, she has led multiple clinical programs, including the Non‑Invasive Liver Fibrosis Assessment Clinic and the CPMC Cholangiocarcinoma Program. A nationally recognized expert in autoimmune liver diseases, primary sclerosing cholangitis (PSC), and primary biliary cholangitis (PBC), Dr. Yimam is an active investigator in numerous international consortia and clinical trials. She has authored extensive peer‑reviewed publications and is a frequent invited speaker at national and international conferences. Dr. Yimam also serves on multiple professional committees, editorial boards, and global research groups, contributing to advancements in hepatology practice and patient care. Committed to mentorship and global health, she co‑founded international training initiatives and community support programs. Outside of medicine, she enjoys running, cooking, and spending time with her family.
Research studies
- Research study
Cholangitis Observational Cohort WIND-PSC
A Global Multi-Center Prospective Observational Cohort to Support Drug Development in Adult Patients with Primary Sclerosing Cholangitis (WIND-PSC)
Clinical trials
- Clinical trial
Primary Biliary Cholangitis (PBC) AFFIRM
AFFIRM: A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Seladelpar on Clinical Outcomes in Patients With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
Status: Open to Enrollment




